Trieu Vuong, Chairman and CEO of Oncotelic Therapeutics, Inc. ($OTLC), made three open market purchases of company shares in the last 365 days, totaling $993.69. His most recent buy occurred on July 10, 2025. These purchases rank him 4,812th among nearly 5,000 insiders in our database by total amount bought, compared to an average of $1.46 million per insider and about 3.3 transactions. Vuong reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 22, 2026 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | A | Series A Convertible Preferred Stock | 4426 | $0.00 | 8,491.0000 | 440,778,404 | 108.88% | 0.00% |
| Nov. 17, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | A | Series A Convertible Preferred Stock | 4065 | $0.00 | 4,065.0000 | 440,778,404 | 9999.99% | 0.00% |
| July 8, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 94736 | $0.01 | 117,041,210.0000 | 408,292,450 | 0.08% | 0.02% |
| July 10, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 104000 | $0.01 | 116,946,473.0000 | 408,292,450 | 0.09% | 0.03% |
| July 9, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 1 | $0.01 | 116,946,474.0000 | 408,292,450 | 0.00% | 0.00% |
| Jan. 31, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 63775 | $0.03 | 116,842,473.0000 | 0 | 0.05% | 0.00% |
| Jan. 30, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 100003 | $0.03 | 116,778,698.0000 | 0 | 0.09% | 0.00% |
| Jan. 29, 2025 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 183066 | $0.03 | 116,678,695.0000 | 0 | 0.16% | 0.00% |
| Nov. 22, 2024 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 298499 | $0.03 | 116,495,629.0000 | 0 | 0.26% | 0.00% |
| Aug. 23, 2024 | Oncotelic Therapeutics, Inc. | $OTLC | Trieu Vuong | CHAIRMAN AND CEO | P | Common Stock | 500000 | $0.02 | 116,197,130.0000 | 0 | 0.43% | 0.00% |